載入...
Heterogeneous responses in hepatocellular carcinoma: the achilles heel of immune checkpoint inhibitors
Treatment of patients with hepatocellular carcinoma (HCC) remains a serious challenge due to high heterogeneity and limited treatment options. In the past few decades, immune therapy, especially immune checkpoint therapy, has become an alternative option for the treatment of malignancies including H...
Na minha lista:
| 發表在: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
e-Century Publishing Corporation
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7191099/ https://ncbi.nlm.nih.gov/pubmed/32368387 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|